FSD Pharma Inc. (HUGE): Price and Financial Metrics
HUGE Price/Volume Stats
| Current price | $1.18 | 52-week high | $2.10 |
| Prev. close | $1.26 | 52-week low | $0.62 |
| Day low | $1.14 | Volume | 131,200 |
| Day high | $1.28 | Avg. volume | 150,684 |
| 50-day MA | $1.16 | Dividend yield | N/A |
| 200-day MA | $1.30 | Market Cap | 46.07M |
HUGE Stock Price Chart Interactive Chart >
FSD Pharma Inc. (HUGE) Company Bio
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.
Latest HUGE News From Around the Web
Below are the latest news stories about FSD PHARMA INC that investors may wish to consider to help them evaluate HUGE as an investment opportunity.
FSD Pharma Inc. Securityholders Approve Plan of Arrangement with Celly Nutrition Corp.TORONTO, ON / ACCESSWIRE / November 21, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased ... |
FSD Pharma Announces Distribution Date for Distribution of Celly Shares Pursuant to Plan of ArrangementTORONTO, ON / ACCESSWIRE / November 17, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased ... |
FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023TORONTO, ON / ACCESSWIRE / November 15, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions,is pleased to ... |
FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One BasisTORONTO, ON / ACCESSWIRE / November 7, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions,is pleased to ... |
FSD Pharma Files Preliminary Base Shelf Prospectus to Replace Expired Base Shelf ProspectusTORONTO, ON / ACCESSWIRE / November 6, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to ... |
HUGE Price Returns
| 1-mo | 19.19% |
| 3-mo | -8.53% |
| 6-mo | -3.28% |
| 1-year | 32.93% |
| 3-year | -23.87% |
| 5-year | -98.04% |
| YTD | 49.67% |
| 2022 | -22.71% |
| 2021 | -34.62% |
| 2020 | -71.26% |
| 2019 | -87.37% |
| 2018 | 755.60% |
Loading social stream, please wait...